## Review setup
- **Input scope** Full manuscript text (abstract, introduction, methods, results, discussion, conclusions) as provided by the user. No supplementary materials, figures, or tables were included beyond textual descriptions.
- **Assessment boundary** This review evaluates the scientific claims, methodological rigor, data interpretation, and internal consistency of the manuscript as presented. It does not assess the editorial fit for a specific journal, nor does it verify external data or literature beyond what is cited within the text.
- **Shared manuscript claim summary** The authors propose that exposure of human lung fibroblasts (MRC-5) to trihalomethanes (CH2Cl2, CHCl3, BrCHCl2) induces reactive oxygen species (ROS) production, which correlates with oxidative stress biomarkers and antioxidant enzyme activities. They further claim, based on molecular docking and molecular dynamics simulations, that these compounds and ROS interact with the IPT domain of the NF-κB/p65 subunit, potentially facilitating IκBα/NF-κB complex dissociation and subsequent NF-κB activation, with the extent of chlorination influencing the response.
- **Visible evidence base** The evidence base consists of the manuscript text only. This includes descriptions of experimental methods (cell culture, ROS assays, enzyme activity assays, ELISA for phospho-NF-κB/p65, molecular docking, and MD simulations), results summaries (including references to Figures 1, 3, 4, 5, 6, 7 and Tables 1, 2), and statistical analysis descriptions. No raw data, actual figures, tables, or supplementary information were provided.
- **Missing materials affecting confidence** The absence of actual figures, tables, and raw numerical data significantly limits the ability to verify the reported results, effect sizes, statistical significance, and the validity of the computational models. Specific details on assay protocols, antibody validation, and simulation parameters are also incomplete.

## Reviewer
- **Overall assessment** This manuscript addresses a relevant and potentially important question regarding the molecular mechanisms linking environmental contaminant exposure (trihalomethanes) to oxidative stress and inflammatory signaling in a relevant human cell type. The combination of cellular assays with computational modeling is a commendable approach. However, the current presentation has significant weaknesses. The link between the experimental observations (ROS, enzyme activities, phospho-NF-κB levels) and the computational predictions (docking, MD) is largely correlative and speculative. The manuscript lacks a clear, mechanistic demonstration that the proposed molecular interactions are causally responsible for the observed cellular effects. The narrative is often difficult to follow, with some logical jumps and a lack of clear integration between the different data types. The conclusions are overstated relative to the evidence presented.
- **Who would be interested in the results, and why** Researchers in the fields of environmental toxicology, oxidative stress biology, and pulmonary biology would find this work of interest. Specifically, those studying the health effects of disinfection byproducts, the role of ROS in cellular signaling, and the regulation of NF-κB in lung inflammation and fibrosis would be the primary audience. The potential link between a common environmental exposure and a key inflammatory pathway could have public health implications.
- **Major strengths**
    1.  The study addresses a relevant and under-explored question: the direct effect of trihalomethanes on ROS production and NF-κB signaling in human lung fibroblasts.
    2.  The use of a human lung fibroblast cell line (MRC-5) is a relevant model for studying inhalation exposure.
    3.  The combination of in vitro cellular assays with in silico molecular modeling is a modern and potentially powerful approach to generate and support hypotheses.
    4.  The study examines a panel of related compounds (CH2Cl2, CHCl3, BrCHCl2), allowing for structure-activity relationship considerations.
- **Major Concerns**

    - **Concern ID** R1-M1
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Experimental Design and Data Interpretation
    - **Claim pointer** The manuscript claims a direct mechanistic link between HM-induced ROS production, the activity of antioxidant enzymes, and the phosphorylation/dissociation of the NF-κB pathway, culminating in a specific role for the IPT domain.
    - **Evidence pointer** Sections 3.1-3.5, Figures 1, 3, 4, 5, 6, 7, Tables 1, 2.
    - **Concern** The experimental design is purely correlative. The authors measure ROS, enzyme activities, and phospho-NF-κB levels in response to HM exposure, and then use molecular docking to propose a mechanism. However, there are no experiments that directly test the proposed mechanism. For example, there is no use of ROS scavengers (e.g., NAC, catalase) to see if blocking ROS prevents NF-κB activation. There is no use of siRNA or inhibitors to knock down or block the proposed target residues (e.g., Ser281) to see if the effect is lost. There is no direct measurement of IκBα degradation or NF-κB nuclear translocation. The causal chain from HM exposure to ROS to NF-κB activation is inferred, not demonstrated.
    - **Why it matters** Without direct experimental intervention, the central hypothesis of the paper remains unproven. The observed correlations could be coincidental or due to off-target effects. The computational model provides a plausible hypothesis, but it is not a substitute for experimental validation. The claim that the IPT domain is the key mediator is particularly unsupported, as no experiments target this domain.
    - **Resolution test** The authors should perform experiments that directly test the causal role of ROS and the NF-κB pathway. This could include: (1) pre-treating cells with ROS scavengers or inhibitors of NADPH oxidase and measuring the effect on HM-induced NF-κB phosphorylation and downstream target gene expression; (2) using siRNA or CRISPR to knock down p65 or IκBα and assessing the impact on HM-induced hyperproliferation; (3) performing a reporter gene assay to directly measure NF-κB transcriptional activity; (4) using a mutant p65 construct lacking the proposed phosphorylation site (e.g., S281A) to see if the response to HMs is altered.

    - **Concern ID** R1-M2
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Computational Modeling and Validation
    - **Claim pointer** The manuscript claims that molecular docking and MD simulations show that HMs and ROS bind to the IPT domain of NF-κB/p65 with specific affinities, and that this binding is functionally relevant.
    - **Evidence pointer** Section 2.5, Section 3.5, Figures 5, 6, 7, Table 2.
    - **Concern** The computational methodology is described with insufficient detail to be reproducible or to assess its validity. Key parameters are missing, such as the specific docking scoring function settings, the preparation of the protein structure (e.g., protonation states, missing residues), the length and conditions of the MD simulations (e.g., ensemble, temperature, pressure coupling), and the method for calculating binding free energies (e.g., MM-PBSA, thermodynamic integration). The manuscript mentions "thermodynamic integration" in the abstract but the methods section describes a different approach. The reported ΔG values are inconsistent between the abstract (-3.3 to -3.6 kcal/mol) and the results section (-7.0 to -7.6 kcal/mol). The significance of the "HUMO-LUMO" (likely HOMO-LUMO) energies and SCF calculations is not explained in a biological context. The claim that a binding energy of -7.0 kcal/mol is "effective" is not benchmarked against any known inhibitor or validated by any experimental binding assay.
    - **Why it matters** The computational results are a cornerstone of the paper's mechanistic claim. If the methodology is flawed or the results are not reproducible, the entire hypothesis is weakened. The inconsistencies in the reported energies are a major red flag. Without proper validation (e.g., comparing docking poses to known crystal structures, or using a more rigorous free energy method), the conclusions drawn from the modeling are not reliable.
    - **Resolution test** The authors must provide a complete and detailed description of their computational methods, including all parameters and software versions. They must reconcile the conflicting ΔG values reported in the abstract and results. They should validate their docking protocol by re-docking a known ligand to the p65 structure and comparing the pose. They should also consider using a more robust method for calculating binding free energies, such as MM-PBSA or MM-GBSA, and clearly state the limitations of their approach.

    - **Concern ID** R1-M3
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Data Presentation and Statistical Rigor
    - **Claim pointer** The manuscript claims statistically significant changes in ROS levels, enzyme activities, and phospho-NF-κB levels, and significant correlations between biomarkers.
    - **Evidence pointer** Sections 3.1-3.4, Figures 1, 3, 4, Table 1.
    - **Concern** The results are described in the text, but the actual data (figures and tables) are not provided for review. The statistical analysis section is very brief. It mentions ANOVA and Pearson correlation, but does not specify the type of ANOVA (one-way, two-way), the post-hoc tests used (beyond mentioning Dunnett's for solvent controls), or how assumptions of normality and homogeneity of variance were tested. The use of the Kruskal-Wallis test for phospho-NF-κB data is mentioned, but it is unclear why this non-parametric test was chosen for this specific dataset. The text describes "irregular" and "inconsistent" effects, which suggests high variability in the data, but the source of this variability is not discussed. The correlation analysis is described, but the strength and direction of the correlations are not quantified in the text.
    - **Why it matters** The scientific validity of the conclusions rests entirely on the quality and interpretation of the data. Without seeing the actual data, it is impossible to assess whether the claims are justified. The lack of detail on statistical methods makes it difficult to trust the reported p-values. The description of "irregular" effects suggests that the biological system is noisy, and the authors need to demonstrate that their findings are robust and not driven by outliers.
    - **Resolution test** The authors must provide the actual figures and tables with clear error bars and individual data points. They must provide a complete description of their statistical methods, including the specific tests used, how assumptions were checked, and how multiple comparisons were handled. They should also provide the results of the correlation analysis, including correlation coefficients and p-values.

- **Minor Comments**

    - **Concern ID** R1-m1
    - **Severity** Minor
    - **Axis** Clarity and Terminology
    - **Affected element** Title and Abstract
    - **Evidence pointer** Title, Abstract
    - **Issue** The title is overly specific and claims a definitive mechanism ("Promotes the IkappaBalpha/NF-kappaB/p65 Complex Dissociation") that is not directly demonstrated by the experimental data. The abstract contains a specific numerical value for binding energy (-3.3 kcal/mol) that is not consistent with the results section.
    - **Required correction** The title should be more cautious, e.g., "Trihalomethane Exposure Induces ROS and Correlates with NF-κB/p65 Phosphorylation in Human Lung Fibroblasts." The abstract should be revised to remove the specific binding energy value or ensure consistency with the results section.

    - **Concern ID** R1-m2
    - **Severity** Minor
    - **Axis** Methodology Detail
    - **Affected element** Section 2.1
    - **Evidence pointer** Section 2.1
    - **Issue** The concentration range of HMs used (10^-4 to 10^-20 mol) is extremely wide and includes concentrations that are likely not physiologically or environmentally relevant. The rationale for this range is not provided.
    - **Required correction** The authors should justify the concentration range used and discuss its relevance to real-world exposure scenarios.

    - **Concern ID** R1-m3
    - **Severity** Minor
    - **Axis** Methodology Detail
    - **Affected element** Section 2.2
    - **Evidence pointer** Section 2.2
    - **Issue** The methods for ROS quantification are described as "established protocols" but the specific details (e.g., the exact fluorescent probes used, excitation/emission wavelengths, and how the calibration curve was constructed) are not provided.
    - **Required correction** Provide more detail on the ROS assays, including the specific probes and their concentrations, to allow for reproducibility.

    - **Concern ID** R1-m4
    - **Severity** Minor
    - **Axis** Data Interpretation
    - **Affected element** Section 3.1
    - **Evidence pointer** Section 3.1
    - **Issue** The text states that CH2Cl2 and BrCHCl2 had "variable" and "inconsistent" effects on ROS levels. This is a critical observation that is not adequately explained. It undermines the general claim that HMs induce ROS.
    - **Required correction** The authors should discuss the variability in their data and propose potential explanations (e.g., differential metabolism, solubility issues, or experimental variability).

    - **Concern ID** R1-m5
    - **Severity** Minor
    - **Axis** Discussion and Literature Context
    - **Affected element** Section 4
    - **Evidence pointer** Section 4
    - **Issue** The discussion is largely a restatement of the results and does not adequately place the findings in the context of the broader literature on NF-κB regulation by ROS. The authors do not discuss alternative mechanisms by which HMs could activate NF-κB (e.g., direct modification of upstream kinases).
    - **Required correction** The discussion should be expanded to consider alternative mechanisms and to more thoroughly compare the findings with existing studies on HM toxicity and NF-κB signaling.

    - **Concern ID** R1-m6
    - **Severity** Minor
    - **Axis** Clarity and Terminology
    - **Affected element** Section 3.5
    - **Evidence pointer** Section 3.5
    - **Issue** The term "HUMO-LUMO" is a typo and should be "HOMO-LUMO". The relevance of these frontier orbital energies to the biological system is not explained.
    - **Required correction** Correct the typo and provide a clear explanation of why HOMO-LUMO energies are relevant to the proposed mechanism.

## Risk / unsupported claims
- The central mechanistic claim that HM-induced ROS directly causes IκBα/NF-κB complex dissociation via interaction with the IPT domain is unsupported by direct experimental evidence. It is a hypothesis based on correlative data and computational predictions.
- The claim that BrCHCl2 "may more effectively facilitate the dissociation of the IκBα-NF-κB complex" is speculative and not directly tested.
- The specific binding energy values for HMs and ROS to NF-κB/p65 are inconsistent between the abstract and results, and their calculation method is not fully described, making them unreliable.
- The claim that the studied concentrations are "biologically relevant" is not adequately justified.
- The statement that "ROS can either inhibit or stimulate NF-κB signaling pathways" is presented without a clear synthesis of how the current findings fit into this complex picture.
- The conclusion that "ROS may disrupt the expression of other genes... potentially compromising the cell's ability to combat oxidative damage" is a broad speculation not directly supported by the data presented.